Pharma R&D
Pharma R&D
Pharma R&D
Pharma R&D
INNOVATION
IN GENOMICS
GMDx Genomics is a clinical diagnostic company that has developed a ‘platform technology’ which provides novel insights into a person’s DNA to determine the health of their immune system.
It’s lead application is to accurately predict cancer patient responses to immunotherapy drugs.
In many people, these new drugs have life-threatening side-effects, and the GMDx tests allows Oncologists to deliver personalized treatment plans by predicting patient response.
Our executives explain the incredible work that has been achieved by GMDx and our dedicated team.
GMDx has multiple scientifically published, patented genomic discoveries to develop tests in cancer for treatment selection, disease progression and early detection.
The GMDx enabling platform utilizes an industry-leading framework built on the Oracle Autonomous Cloud. The platform is readily accessible to GMDx partners globally. The Oracle partnership ensures compliance with all privacy and security requirements.